NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,189 Cr | ₹856 Cr | ₹621 Cr | ₹413 Cr | ₹551 Cr |
What is the latest Sundry Debtors ratio of NATCO PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹1,189 Cr |
Mar2023 | ₹856 Cr |
Mar2022 | ₹621 Cr |
Mar2021 | ₹413 Cr |
Mar2020 | ₹551 Cr |
How is Sundry Debtors of NATCO PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹1,189 Cr | 38.87 | |
Mar2023 | ₹856 Cr | 37.95 | |
Mar2022 | ₹621 Cr | 50.30 | |
Mar2021 | ₹413 Cr | -25.10 | |
Mar2020 | ₹551 Cr | - |
Compare Sundry Debtors of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,823.5 Cr | 4.5% | 7.1% | -11.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,032.0 Cr | 0.9% | 2.2% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,252.0 Cr | 3.3% | 4.7% | 58% | Stock Analytics | |
CIPLA | ₹124,457.0 Cr | 0.5% | 2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,425.0 Cr | -0.4% | 2.8% | 24.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,152.8 Cr | -0.8% | -0.4% | 0.8% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 4.5% |
7.1% |
-11.6% |
SENSEX | 0.9% |
3% |
8.9% |
You may also like the below Video Courses